Philips Named a Derwent Top 100 Global Innovator for the 7th Consecutive Year

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has again been recognized as a Derwent Top 100 Global Innovator™ in Clarivate Analytics' annual analysis of the global innovation ecosystem. The Derwent Top 100 Global Innovators report identifies the world's most innovative organizations, those that successfully develop valuable patented inventions with strong commercialization potential based on their market reach and impact on other downstream inventions [1]. Philips has successively won a place on this prestigious list for the last seven years.

"Philips' innovation strength is powering our drive to provide integrated solutions that improve people's health across the health continuum," said Frans van Houten, CEO of Royal Philips. "I am pleased that we have once again been recognized, for the 7th consecutive year, as a Derwent Top 100 Global Innovator by Clarivate Analytics. I remain convinced that our ongoing commitment to innovation and R&D, combined with our sense of purpose and culture of customer centricity, will continue to drive our mission to make the world healthier and more sustainable."

Philips' EUR 1.9 billion R&D program has resulted in the introduction of many successful innovations, including the new Incisive CT imaging platform for radiology departments, helping them to improve the patient and staff experience, enable smart clinical decision-making and increase efficiency, and the Ingenia Ambition 1.5T MRI system, which enables helium-free operations while delivering superb image quality. Philips also launched the new IntelliVue MX750 and MX850 patient monitors, which feature a wide range of measurements and analytics together with innovative new cybersecurity capabilities. In oral care, the company rolled out its connected Sonicare ExpertClean - a new smart power toothbrush that delivers superior oral care results with sonic technology and deep clean brushing modes.

The Derwent Top 100 Global Innovators™ 2020 report and a full list of the Top 100 organizations named in it can be found here.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 80,000 employees with sales and services in more than 100 countries.

1. The Derwent Top 100 Global Innovators tracks innovation based on four indicators: 1. Volume: The organization must have had at least 100 granted inventions (and more than 500 filed in total) in the past five years. 2. Influence: The level of downstream impact by being highly cited externally by other organizations, and measured via the Derwent Patent Citations Index over the last five years, excluding citations from themselves. 3. Success: A high ratio of success in obtaining patent grants. 4. Globalization: The level of investment of a patent applicant in their invention, as tracked via the process of pursuing protection in all four of the key market patent offices of China, Europe, Japan, and the United States.

Most Popular Now

App Determines COVID-19 Disease Severity…

A new mobile app can help clinicians determine which patients with the novel coronavirus (COVID-19) are likely to have severe cases. Created by researchers at NYU College of Dentistry, the...

NHS Trust Revolutionises Access to Menta…

North Staffordshire Combined Healthcare NHS Trust has selected the DXC Open Health Connect platform from DXC Technology (NYSE: DXC) and is creating a blueprint that could dramatically reduce mental health...

FDA Permits Marketing of First Game-Base…

The U.S. Food and Drug Administration (FDA) permitted marketing of the first game-based digital therapeutic device to improve attention function in children with attention deficit hyperactivity disorder (ADHD). The prescription-only...

HealthTunes Launches iOS App to Deliver …

HealthTunes has announceed the launch of the iOS App specifically created to help alleviate the mental health suffering of frontline healthcare workers. After months of fighting the pandemic, many frontline...

Philips Announces Collaboration with Ame…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has once again joined forces with the American Telemedicine Association (ATA) to help further the...

Bluetooth Technology, the Best Ally to D…

"Tracers have been and are essential to manage the pandemic. Today, the tracing is done by hand and this work is slow and inaccurate. However, as we have seen, technology...

Successful Debut for DMEA sparks

16 - 18 June 2020, Berlin, Germany. DMEA sparks opened, featuring a wide range of topics. Federal Minister of Health Jens Spahn kicked off events. In his interview he focused on...

Digital Mental Health support to be Prov…

SilverCloud, the leading digital therapeutics provider, has partnered with mental health charity Northpoint Wellbeing to co-develop a new digital therapy programme to alleviate anxiety in young people. Coming at a...

Siemens Healthineers Uses Artificial Int…

Siemens Healthineers introduces Ysio X.pree(1), the world's first intelligent X-ray system with integrated AI for optimizing the daily routine of image acquisition in radiography. To assist radiologists with the subsequent...

Siemens Healthineers Offers Flexible Tel…

With its teamplay myCare Companion software, the company is bringing a new and flexible telemedicine solution to the market that enables remote care for patients with chronic diseases. The teamplay...

Computer Modelling Predicts where Vaccin…

Researchers have developed a model that can estimate regional disease burden and the impact of vaccination, even in the absence of robust surveillance data, a study in eLife reveals. The report...

Andrea Fiumicelli Appointed as a CEO of …

Dedalus Group, leader in Europe and one of the world's leading players in clinical and healthcare information systems supporting clinical professionals and healthcare facilities thanks to a wide portfolio of...